ICT induces antitumor immune responses in hepatocellular carcinoma by downregulating alpha fetoprotein gene expression and exacerbating mitophagy and synergizes with doxorubicin to induce immunogenic cell death in hepatocellular carcinoma (Yu et al., 2020). This evidence concerns the gene AFP and hepatocellular carcinoma.